INTERNATIONAL PATENT: MEREO BIOPHARMA 4 LIMITED, THE UAB RESEARCH FOUNDATION FILES APPLICATION FOR "USE OF ALVELESTAT IN SPECIFIC PATIENTS"

GENEVA, July 2 -- MEREO BIOPHARMA 4 LIMITED (1 Cavendish PlaceLondon W1G 0QF), THE UAB RESEARCH FOUNDATION (710 13th Street South120 Collat School of BusinessBirmingham, Alabama 35233) filed a patent application (PCT/GB2024/053186) for "USE OF ALVELESTAT IN SPECIFIC PATIENTS" on Dec 20, 2024. With publication no. WO/2025/133628, the details related to the patent application was published on Jun 26, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): PARKIN, Jacqueline (c/o Mereo Biopharma 4 Limited1 Cavendish PlaceLondon W1G 0QF), FETTIPLACE, James (c/o Mereo Biopharma 4 Limited1 Cavendish Place...